Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Amyloid precursor-like protein 2 (APLP2) is modified by the addition of chondroitin sulfate glycosaminoglycan at a single site.
Clinician attitudes and practices toward measurable residual disease in multiple myeloma.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinician attitudes and practices toward measurable residual disease in multiple myeloma.
Clinician attitudes and practices toward measurable residual disease in multiple myeloma. Br J Haematol. 2020 08; 190(3):470-472.
View in:
PubMed
subject areas
Attitude of Health Personnel
Bone Marrow Examination
Clinical Decision-Making
Disease Progression
Flow Cytometry
Health Care Surveys
Health Knowledge, Attitudes, Practice
High-Throughput Nucleotide Sequencing
Humans
Multiple Myeloma
Neoplasm, Residual
Physicians
Positron Emission Tomography Computed Tomography
Practice Patterns, Physicians'
Sensitivity and Specificity
Surveys and Questionnaires
Time Factors
authors with profiles
Andrzej Jakubowiak
Benjamin Derman